Browse Catalog by Subject
Catalog|Healthcare and Pharmaceuticals|Pharmaceuticals (24327 reports)
Additional Filter:

Sort by:

<< prev 1 2 3 4 5 6 7 8 9 10 next >>

226 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
227 Acorda Therapeutics, Inc. (ACOR) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
228 Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
229 AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
230 Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
231 AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
232 BioAlliance Pharma SA (BIO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
233 Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
234 BioElectronics Corporation (BIEL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
235 BioLineRx, Ltd. (BLRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
236 Ceapro Inc. (CZO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
237 Cellavision AB (CEVI) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
238 Cyprotex PLC (CRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
239 DARA BioSciences, Inc. (DARA) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
240 Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
241 Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
242 Intercell AG (ICLL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
243 Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
244 Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
245 Mast Therapeutics, Inc. (MSTX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
246 Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
247 MMRGlobal, Inc. (MMRF) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
248 Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
249 Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
250 NovaDel Pharma, Inc. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125

<< prev 1 2 3 4 5 6 7 8 9 10 next >>